ZENVIA INC - A (ZENV) Fundamental Analysis & Valuation

NASDAQ:ZENV • KYG9889V1014

Current stock price

0.4689 USD
-0.13 (-21.84%)
At close:
0.4802 USD
+0.01 (+2.41%)
After Hours:

This ZENV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ZENV Profitability Analysis

1.1 Basic Checks

  • ZENV had negative earnings in the past year.
  • ZENV had a positive operating cash flow in the past year.
  • ZENV had negative earnings in each of the past 5 years.
  • Of the past 5 years ZENV 4 years had a positive operating cash flow.
ZENV Yearly Net Income VS EBIT VS OCF VS FCFZENV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • ZENV has a Return On Assets (-7.21%) which is comparable to the rest of the industry.
  • The Return On Equity of ZENV (-16.24%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -7.21%
ROE -16.24%
ROIC N/A
ROA(3y)-8.63%
ROA(5y)-6.61%
ROE(3y)-17.47%
ROE(5y)-14.93%
ROIC(3y)N/A
ROIC(5y)N/A
ZENV Yearly ROA, ROE, ROICZENV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • In the last couple of years the Operating Margin of ZENV has declined.
  • ZENV's Gross Margin of 22.27% is on the low side compared to the rest of the industry. ZENV is outperformed by 82.37% of its industry peers.
  • ZENV's Gross Margin has improved in the last couple of years.
  • ZENV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.27%
OM growth 3YN/A
OM growth 5Y-41.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.3%
GM growth 5Y3.13%
ZENV Yearly Profit, Operating, Gross MarginsZENV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ZENV Health Analysis

2.1 Basic Checks

  • ZENV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ZENV has more shares outstanding
  • Compared to 5 years ago, ZENV has more shares outstanding
  • ZENV has a worse debt/assets ratio than last year.
ZENV Yearly Shares OutstandingZENV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ZENV Yearly Total Debt VS Total AssetsZENV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • ZENV has an Altman-Z score of 0.18. This is a bad value and indicates that ZENV is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.18, ZENV is doing worse than 68.70% of the companies in the same industry.
  • The Debt to FCF ratio of ZENV is 2.31, which is a good value as it means it would take ZENV, 2.31 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.31, ZENV is in the better half of the industry, outperforming 65.11% of the companies in the same industry.
  • ZENV has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • ZENV has a Debt to Equity ratio of 0.02. This is in the better half of the industry: ZENV outperforms 60.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 2.31
Altman-Z 0.18
ROIC/WACCN/A
WACC14.92%
ZENV Yearly LT Debt VS Equity VS FCFZENV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • ZENV has a Current Ratio of 0.38. This is a bad value and indicates that ZENV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZENV has a Current ratio of 0.38. This is amonst the worse of the industry: ZENV underperforms 93.53% of its industry peers.
  • ZENV has a Quick Ratio of 0.38. This is a bad value and indicates that ZENV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZENV has a Quick ratio of 0.38. This is amonst the worse of the industry: ZENV underperforms 92.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38
ZENV Yearly Current Assets VS Current LiabilitesZENV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ZENV Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 10.04% over the past year.
  • ZENV shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.80%.
  • Measured over the past years, ZENV shows a very strong growth in Revenue. The Revenue has been growing by 22.07% on average per year.
EPS 1Y (TTM)10.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-145.26%
Revenue 1Y (TTM)24.8%
Revenue growth 3Y16.16%
Revenue growth 5Y22.07%
Sales Q2Q%23.6%

3.2 Future

  • ZENV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.67% yearly.
  • Based on estimates for the next years, ZENV will show a small growth in Revenue. The Revenue will grow by 0.89% on average per year.
EPS Next Y62.14%
EPS Next 2Y38.85%
EPS Next 3Y29.67%
EPS Next 5YN/A
Revenue Next Year4.14%
Revenue Next 2Y-0.48%
Revenue Next 3Y0.89%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZENV Yearly Revenue VS EstimatesZENV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ZENV Yearly EPS VS EstimatesZENV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

3

4. ZENV Valuation Analysis

4.1 Price/Earnings Ratio

  • ZENV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ZENV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZENV Price Earnings VS Forward Price EarningsZENV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • 98.20% of the companies in the same industry are more expensive than ZENV, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZENV indicates a rather cheap valuation: ZENV is cheaper than 98.56% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.11
EV/EBITDA 2.28
ZENV Per share dataZENV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ZENV's earnings are expected to grow with 29.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.85%
EPS Next 3Y29.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZENV Dividend Analysis

5.1 Amount

  • No dividends for ZENV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZENV Fundamentals: All Metrics, Ratios and Statistics

ZENVIA INC - A

NASDAQ:ZENV (3/18/2026, 8:00:02 PM)

After market: 0.4802 +0.01 (+2.41%)

0.4689

-0.13 (-21.84%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-01
Earnings (Next)N/A
Inst Owners7.01%
Inst Owner Change-6.17%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap24.65M
Revenue(TTM)1.10B
Net Income(TTM)-120.56M
Analysts43.33
Price Target1.43 (204.97%)
Short Float %1.28%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)17.76%
Min Revenue beat(2)9.65%
Max Revenue beat(2)25.87%
Revenue beat(4)3
Avg Revenue beat(4)9.35%
Min Revenue beat(4)-9.77%
Max Revenue beat(4)25.87%
Revenue beat(8)7
Avg Revenue beat(8)85.13%
Revenue beat(12)8
Avg Revenue beat(12)73.96%
Revenue beat(16)10
Avg Revenue beat(16)54.24%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF 3.11
P/OCF 1.53
P/B 0.17
P/tB N/A
EV/EBITDA 2.28
EPS(TTM)-0.58
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.15
FCFY32.19%
OCF(TTM)0.31
OCFY65.5%
SpS3.97
BVpS2.69
TBVpS-2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.21%
ROE -16.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.27%
FCFM 3.8%
ROA(3y)-8.63%
ROA(5y)-6.61%
ROE(3y)-17.47%
ROE(5y)-14.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-41.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.3%
GM growth 5Y3.13%
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 2.31
Debt/EBITDA 0.21
Cap/Depr 48.68%
Cap/Sales 3.93%
Interest Coverage N/A
Cash Conversion 107.17%
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z 0.18
F-Score4
WACC14.92%
ROIC/WACCN/A
Cap/Depr(3y)64.4%
Cap/Depr(5y)60.76%
Cap/Sales(3y)6.52%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-145.26%
EPS Next Y62.14%
EPS Next 2Y38.85%
EPS Next 3Y29.67%
EPS Next 5YN/A
Revenue 1Y (TTM)24.8%
Revenue growth 3Y16.16%
Revenue growth 5Y22.07%
Sales Q2Q%23.6%
Revenue Next Year4.14%
Revenue Next 2Y-0.48%
Revenue Next 3Y0.89%
Revenue Next 5YN/A
EBIT growth 1Y-14.67%
EBIT growth 3YN/A
EBIT growth 5Y-28.23%
EBIT Next Year115.56%
EBIT Next 3Y64.67%
EBIT Next 5YN/A
FCF growth 1Y-75.71%
FCF growth 3YN/A
FCF growth 5Y23.72%
OCF growth 1Y-62.73%
OCF growth 3YN/A
OCF growth 5Y32.39%

ZENVIA INC - A / ZENV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ZENVIA INC - A?

ChartMill assigns a fundamental rating of 3 / 10 to ZENV.


Can you provide the valuation status for ZENVIA INC - A?

ChartMill assigns a valuation rating of 3 / 10 to ZENVIA INC - A (ZENV). This can be considered as Overvalued.


Can you provide the profitability details for ZENVIA INC - A?

ZENVIA INC - A (ZENV) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for ZENV stock?

The Earnings per Share (EPS) of ZENVIA INC - A (ZENV) is expected to grow by 62.14% in the next year.